Yoon Seok-yeol was elected president

Expectation of establishing a pharmaceutical innovation committee under the direct control of the Prime Minister

With 48.59% of the votes, 0.73% ahead of Lee Jae-myung

Attention is focusing on the pledge to establish a global vaccine hub and quickly register health insurance for severe treatments.

 

In the 20th presidential election, Yoon Seok-yeol, the power of the people, was confirmed to win the election, beating Lee Jae-myung of the Democratic Party of Korea.

 

Candidate Yoon Seok-yeol won 48.56% (16,394,815 votes) as a result of the final vote counting, beating Candidate Lee Jae-myung with 47.83% (16,147,738 votes) by 0.73%p.

 

With candidate Yoon's election, the domestic pharmaceutical bio industry will be able to positively predict the realization of pledges such as the establishment of a "pharmaceutical bio-innovation committee" directly under the Prime Minister.

 

In the JTBC exit survey with the three terrestrial broadcasters released shortly after the end of the 20th presidential election at 7:30 p.m.

 

on the 9th, candidate Yoon and candidate Lee showed a close race with a 0.6% to 0.7%.

 

The situation between the two candidates continued to be close enough to gauge Yoon's election potential only at 2 a.m.

 

on the 10th, a day after the voting day, when the nation's vote counting rate was close to 90%.

 

Candidate Yoon was not sure of his election until after 3:30 a.m.

 

on the same day.

 

The end time of the vote counting was 6:18 a.m.

 

on the 10th, with the final vote rate of 48.56% for candidate Yoon and 47.83% for candidate Lee.

 

Candidate Yoon, who was elected president, pledged to establish a pharmaceutical bio innovation committee directly under the Prime Minister in the pharmaceutical bio field.

 

This is evaluated as a pledge that actively reflects the "establishment of a pharmaceutical bio control tower directly under the President" proposed by the KPBMA to the government and ruling and opposition presidential candidates.

 

Along with the national R&D expansion policy to build a global vaccine hub, candidate Yoon's pledge is to strengthen access to new drugs for patients by introducing expensive anticancer drugs and rapid registration of new drugs for severe and rare diseases.

 

The COVID-19 infectious disease response system is expected to be reorganized quickly.

 

Candidate Yoon plans to completely reorganize the COVID-19 response system within 100 days of power to conduct scientific and data-based quarantine.

 

In addition, some expect that the policy pledge of the People's Party Ahn Cheol Soo, which agreed to dramatically unify with candidate Yoon before the presidential election, will be absorbed into candidate Yoon's pledge in the future.

 

In an interview with Dailypharm, candidate Ahn Cheol Soo expressed his vision to enter the G5 country using the pharmaceutical bio industry as a new growth engine.

 

The intention was to secure super-difference technology in the pharmaceutical bio sector to foster world-class pharmaceutical companies such as Pfizer and Moderna and discover new global blockbuster drugs.

 

Candidate Ahn agreed to unify and merge with Candidate Yoon, handing over his policy pledge to Candidate Yoon.

 

Shortly after the election, candidate Yoon said, "If we prepare for a new government as elected and officially take over as president, we will respect the constitutional spirit, respect Congress, cooperate with the opposition party, and try to serve the people well." The provisional turnout for the 20th presidential election, compiled by the Central Election Commission, was 77.1%.

 

The figure is 0.1%p short of the final turnout of the 19th presidential election of 77.2%.